Stomach inserts to control weight gain; Onciomed, Inc.; U.S. Pat. No. 8,100,932

U.S. Patent No. 8,100,932, issued on January 24, 2012 to Onciomed, Inc. of Irvine, CA, discloses an expanding intragastric device to reduce a patient’s desire to eat.

 

The ‘932 patent discloses three cylindrical cages that can be placed within the stomach using a minimally-invasive procedure “to occupy volume and to cause a reduced desire for eating for treating obesity and controlling weight gain.”  The first and third cylindrical cages have closed ends, while the second cylindrical cage has open ends and a hollow channel which slows emptying of the stomach since “a limited amount of food can travel through the hollow channel.”

According to its  website, Onciomed is “focused on the development of proprietary, less invasive medical device technology for the treatment of obesity and diabetes,” and its GVS system “enables doctors to perform a procedure that can restrict the intake of food and provide the feeling of fullness.”  Studies are currently underway for the safety and effectiveness of the GVS system and “it is not available for commercial use in the United States.”

The ‘932 patent is the first U.S. patent for Onciomed, according to the USPTO database.

One Response to Stomach inserts to control weight gain; Onciomed, Inc.; U.S. Pat. No. 8,100,932

  1. Pingback: O.C. firm patents device to treat obesity, diabetes - Jan Norman on Small Business : The Orange County Register

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 87 other followers